FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Rescind Remdesivir Orphan Designation: Gilead

Gilead asks FDA to rescind its orphan drug designation of the companys remdesivir as a potential treatment for Covid-19.

Biologics

HCT/Ps Issues at California IVF Fertility Center

FDA warns California IVF Fertility Clinic about significant deviations from HCT/Ps regulations.

Medical Devices

Immediately-in-effect Guidance on Face Masks, Respirators

FDA issues an immediately-in-effect guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease-2019 (COVID-19) Public ...

Biologics

Moderna Covid Vaccine SEC Filing

Moderna tells the SEC its clinical trial of a potential Covid-19 vaccine is proceeding according to protocol and could be offered to healthcare worker...

Human Drugs

Alston Bird FDA Domestic Inspection Analysis

Alston Bird attorneys say the drug industry must be prepared for FDA to creatively use existing authorities instead of physical inspections to ensure ...

Human Drugs

Bristol Myers Pauses New Clinical Trials

Bristol Myers Squibb says it will not initiate any new clinical trials globally before 4/13 due to coronavirus concerns.

Federal Register

April Cosmetics Regulation Meeting Canceled

Federal Register notice: FDA cancels a 4/14 public meeting entitled International Cooperation on Cosmetics Regulation Preparation for ICCR-14 Meeting...

FDA to Fund Real-World Data Projects

FDA says it will fund projects to help it better understand using real-world data to generate real-world evidence.

Human Drugs

PhRMA Concerns with Proprietary Name Study

PhRMA says FDA should change a proposed survey on promotional implications of proprietary drug names if it intends to proceed with the survey.

Biologics

FDA OKs Herceptin Biosimilar Multi-dose Vial

FDA approves a Samsung Bioepis supplemental BLA for a 420 mg multi-dose vial of Ontruzant (trastuzumab-dttb), a biosimilar referencing Genentechs Herc...